Breast cancer is a global cause for concern owing to its high incidence around the world.
The alarming increase in breast cancer cases emphasizes the management of disease at …

Simple Summary Circulating tumor DNA is DNA released by the tumor into the bloodstream.
In breast cancer, it is used mainly in research or in clinical trials, but it will likely be used in …

Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …

Glioblastoma (GBM) is the most common primary tumor of the central nervous system.
Arising from neuroepithelial glial cells, GBM is characterized by invasive behavior, extensive …

Detection of driver gene mutations is important in advanced NSCLC. The cobas EGFR
mutation test is a mutant allele-specific real-time PCR assay with limitation owing to its …

Simple Summary A lack of sensitive biomarkers hinders lung cancer detection and
monitoring, resulting in late diagnosis and missed treatment response. Liquid biopsies have …

Recently, liquid biopsy based on detection of circulating nucleic acid (NA) biomarkers from
body fluids has emerged as a promising strategy for lung cancer monitoring. Considering …

Introduction: Precision medicine is already a reality in oncology, since biomarker-driven
therapies have clearly improved patient survival. Furthermore, a new, minimally invasive …

Burgeoning evidence suggests that circulating tumor cells (CTCs) may disseminate into
blood vessels at an early stage, seeding metastases in various cancers such as breast and …

Lung cancer is one of the highest incidence cancer types worldwide and one with the lowest
5-year survival rate of all cancer types. Despite recent insights into lung cancer …